Preclinical Biotech Deals
The always excellent Bruce Booth wrote a good summary of the key Preclinical deals we've seen so far this year. The post is available here. Some of his broader questions are especially…
Menu
Tips for Attending Conferences
As BD consultants, we attend a number of conferences, both large and small. Some have one-on-one meetings, some don't. Some are scientific conferences, while others are focused on partnering. As…
Biocon Mylan Biogenerics Partnership
Today we learn that generics giant Mylan has entered into a partnership with India-based Biocon to focus on insulin analog biosimilars: Under the terms of this collaboration, Mylan will have…
Drug Delivery is Alive and Well
The announcement of the Allergan acquisition of MAP Pharmaceuticals for nearly $1 billion (and the NuPathe approval) is a good reminder of the potential value (both clinical and financial) of reformulation and drug…
Observations from JPM 2013
Lacerta Bio, along with approximately 10,000 other life science investors, executives, consultants, service providers, hangers-on, and many others, congregated in San Francisco for a variety of conferences, including the JP…
Predictions for 2013
Happy New Year! For many companies, 2012 was a challenging year. How will 2013 play out? Here are a few ideas we've discussed internally as we look forward to 2013:…
Stories of Interest in 2012
As we bring 2012 to a close, we're looking back at a few of the interesting events that took place. It was a challenge to whittle this down to a…
Radio Silence: Three Reasons Why It Happens in BD
Consider the following situation: You are out-licensing an innovative asset in a niche therapeutic area It is a first-in-class molecule It has successfully demonstrated efficacy in two international Phase…
Sandoz closes generic development center in India
Last week, Sandoz announced they are closing a number of generic product development centers around the world, including the Sandoz Development Centre near Mumbai. A few items in this report…
The Decline and Fall of The Monitor Empire
While we were recovering from our turkey-induced slumbers, we read the shocking news that Michael Porter's Monitor Group has filed for bankruptcy, and is being acquired by Delloitte . The…
- Go to the previous page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- …
- 33
- Go to the next page